Stephen Williamson

Professor Emeritus

UNIVERSITY OF KANSAS SCHOOL OF MEDICINE

United States

Research Interests

Explore related searches

Professors in United States Professors in Cancer Biology Cancer Biology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Stephen Williamson is a Professor Emeritus at the University of Kansas School of Medicine. His recent research focuses on advanced cancer therapies, including immunotherapy and targeted treatments for various malignancies. He has contributed to clinical studies on urothelial carcinoma, hepatocellular carcinoma, and the immune response to COVID-19 vaccines in cancer patients. Based in the United States, he specializes in clinical trial methodologies and biomarker evaluations in oncology.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (6)

Anwaar Saeed

University of Pittsburgh

UNITED STATES

View details

Robert Jones

University of Glasgow

UNITED KINGDOM

View details

Hirva Mamdani

Karmanos Cancer Institute

UNITED STATES

View details

Rachel Yoder

University of Kansas Medical Center

UNITED STATES

View details

Mohammed AL-Jumayli

Assistant Professor

University of South Florida

UNITED STATES

View details

Yousef Zakharia

The University of Iowa

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stephen Williamson

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Results from a Phase 1b/2 Study of Ibrutinib Combination Therapy in Advanced Urothelial Carcinoma

A Multicenter, Open-Label, Phase I/II Study of FN-1501 in Patients with Advanced Solid Tumors

Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results.

Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant.

Comparison of Efficacy of Systemic Therapies in Advanced Hepatocellular Carcinoma: Updated Systematic Review and Frequentist Network Meta-Analysis of Randomized Controlled Trials.

Clinical and Biomarker Results from Phase I/II Study of PI3K Inhibitor Alpelisib plus Nab-paclitaxel in HER2-Negative Metastatic Breast Cancer.

Clinical Trial Metrics: The Complexity of Conducting Clinical Trials in North American Cancer Centers.

Association of Neutrophil, Platelet, and Lymphocyte Ratios with the Prognosis in Unresectable and Metastatic Pancreatic Cancer

A Phase II Study of Glembatumumab Vedotin for Metastatic Uveal Melanoma

Immune Checkpoint Inhibitors versus VEGF Targeted Therapy as Second Line Regimen in Advanced Hepatocellular Carcinoma (HCC): A Retrospective Study

Collaborators (6)

Anwaar Saeed

Robert Jones

Hirva Mamdani

Rachel Yoder

Mohammed AL-Jumayli

Yousef Zakharia

Make your next move.